GLAPX — GMO Global Asset Allocation Series Fund

Data updated: 2021-01-29

GLAPX — GMO Global Asset Allocation Series Fund. Money Market · $165.69M AUM · 0.69% expense ratio. Holdings, fees, performance and SEC filings.

GLAPX Fund Overview

GLAPX — GMO Global Asset Allocation Series Fund is a US mutual fund managed by GMO Series Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

Type: US mutual fund
Manager: GMO Series Trust
Category: Money Market
Assets under management: $165.69M
1-year return: 5.5%
Ticker: GLAPX
SEC CIK: 0001521894
SEC series ID: S000035217
Share class ID: C000174014

GLAPX Investment Objective and Strategy

GMO Global Asset Allocation Series Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by GMO Series Trust.

Investment objective

Total return greater than that of its benchmark, the GMO Global Asset Allocation Index, an internally maintained index computed by GMO consisting of 65% MSCI ACWI and 35% Bloomberg Barclays U.S. Aggregate Index.

Principal investment strategy

"The Fund invests substantially all of its assets in Class III shares of GMO Global Asset Allocation Fund (""GAAF""), a series of GMO Trust not offered in this Prospectus. GAAF invests primarily in shares of other funds managed by GMO (""GMO Funds""). The Fund's investment objective and principal investment strategies are substantially similar to those of GAAF. Except as otherwise indicated, references to the Fund may also refer to GAAF, and references to actions undertaken or investments held by the Fund may also refer to those by GAAF. GMO serves as investment adviser for both the Fund and GAAF. The Fund is a fund of funds and invests primarily in shares of other GMO Funds (collectively, the ""underlying GMO Funds""), which may include GMO Funds that invest in equities (collectively, the ""GMO Equity Funds""), GMO Funds that invest in fixed income securities (collectively, the ""GMO Fixed Income Funds""), GMO Funds that are intended to complement other GMO strategies (collectively, the ""GMO Implementation Funds""), and GMO alternative funds (collectively, the ""GMO Alternative Funds"").

The Fund also may invest directly in securities (including other underlying funds) and derivatives. The Fund is permitted to invest in any asset class, including, for example, U.S. and non-U.S. equities (including emerging country equities), U.S. and non-U.S. fixed income securities of any credit quality, including below investment grade securities (commonly referred to as ""junk bonds"") (including emerging country debt securities) and commodities. The term ""equities"" refers to direct and indirect investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. The Fund may invest in securities of companies of any market capitalization. GMO uses its multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to select the underlying GMO Funds in which the Fund invests and to decide how much to invest in each.

An important component of those forecasts is GMO's expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value. GMO changes the Fund's holdings of the underlying GMO Funds in response to changes in GMO's investment outlook and market valuations and may use redemptions or purchases of Fund shares to rebalance the Fund's investments. Under normal circumstances, GMO intends to invest not more than 85% of the Fund's assets in the GMO Equity Funds. The factors GMO considers and investment methods GMO uses can change over time. In seeking to achieve the Fund's investment objective, GMO may invest a significant portion of the Fund's net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in money market funds unaffiliated with GMO and directly in the types of investments typically held by money market funds.

The Fund may hold cash, cash equivalents, and/or U.S. government securities to manage cash inflows and outflows as a result of shareholder purchases and redemptions."

GLAPX Performance

Total returns for GLAPX (as of 2026-10-01), from SEC filings.

Period	Total return
1 year	5.5%

GLAPX Risk Information

Risk metrics for GLAPX, derived from monthly returns in SEC filings.

1-year volatility (annualised): 17.4%

GLAPX Costs and Fees

GLAPX costs about $69 per $10,000 invested per year in fund expenses.

Net expense ratio: 0.69%
Gross expense ratio: 0.80%
Portfolio turnover: 4%
Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)

GLAPX Cashflows

Over the 12 months to 2020-11, GMO Global Asset Allocation Series Fund had net outflows of $12.16M, from monthly SEC N-PORT filings.

Month	Net flow
2020-11	−$742.47K
2020-10	−$4.14M
2020-09	$662.27K
2020-08	−$1.56M
2020-07	−$75.48K
2020-06	−$1.14M

GLAPX Debt Constituents

No individual debt constituents are reported in GMO Global Asset Allocation Series Fund's latest SEC N-PORT filing.

GLAPX Prospectus and SEC Filings

Official GMO Global Asset Allocation Series Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

Related Funds

Other Money Market funds tracked on ABC INVEST:

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.